In Re: John Jennings Appeal from 162nd Judicial District Court of Dallas County (memorandum opinion)

 Annotate this Case
Download PDF
Deny and Opinion Filed August 25, 2022 In The Court of Appeals Fifth District of Texas at Dallas No. 05-22-00804-CV IN RE JOHN JENNINGS, Relator Original Proceeding from the 162nd Judicial District Court Dallas County, Texas Trial Court Cause No. DC-21-10253 MEMORANDUM OPINION Before Justices Myers, Nowell, and Goldstein Opinion by Justice Nowell Before the Court is relator’s August 16, 2022 petition for writ of mandamus. In his petition, relator challenges the trial court’s order denying his motion for summary judgment based on limitations. To be entitled to mandamus relief, relator must show (1) the trial court clearly abused its discretion, and (2) the relator lacks an adequate remedy by appeal. In re Copart, Inc., 619 S.W.3d 710, 713 (Tex. 2021) (orig. proceeding) (citing In re Prudential Ins. Co. of Am., 148 S.W.3d 124, 135–36 (Tex. 2004) (orig. proceeding)). Generally, mandamus relief is not available when a trial court denies a motion for summary judgment, regardless of the merits of the motion. In re United Servs. Auto. Ass’n, 307 S.W.3d 299, 314 (Tex. 2010) (orig. proceeding) (USAA); In re McAllen Med.Ctr., Inc., 275 S.W.3d 458, 465 (Tex. 2008) (orig. proceeding). “Only extraordinary circumstances will justify granting mandamus relief when a trial court erroneously denies a motion for summary judgment.” In re Ooida Risk Retention Grp., Inc., 475 S.W.3d 905, 913 (Tex. App.—Fort Worth 2015, orig. proceeding). After reviewing the petition and mandamus record, we conclude relator has not made such a showing. Accordingly, without expressing any opinion on the trial court’s ruling on the motion for summary judgment, we deny relator’s petition for writ of mandamus. 220804f.p05 /Erin A. Nowell/ ERIN A. NOWELL JUSTICE –2–

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.